Bacterial diversity in urinary tract infections after urological surgeries

Background and aim Urinary tract infections (UTIs) are complications following urological surgeries, with rates depending on the type of procedure and patient population. Patient outcomes, such as morbidity, hospital stay, and healthcare expenditures, can be greatly affected by UTIs. We aim to inves...

Full description

Saved in:
Bibliographic Details
Main Authors: Abdehamead A.A.F. Mohamed, Khaled M. Khalifa, Alaa R. Mahmoud, Ahmed A.A. Kasim
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-01-01
Series:Al-Azhar Assiut Medical Journal
Subjects:
Online Access:https://journals.lww.com/10.4103/azmj.azmj_71_24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850206972774711296
author Abdehamead A.A.F. Mohamed
Khaled M. Khalifa
Alaa R. Mahmoud
Ahmed A.A. Kasim
author_facet Abdehamead A.A.F. Mohamed
Khaled M. Khalifa
Alaa R. Mahmoud
Ahmed A.A. Kasim
author_sort Abdehamead A.A.F. Mohamed
collection DOAJ
description Background and aim Urinary tract infections (UTIs) are complications following urological surgeries, with rates depending on the type of procedure and patient population. Patient outcomes, such as morbidity, hospital stay, and healthcare expenditures, can be greatly affected by UTIs. We aim to investigate the bacterial diversity in UTIs after urological surgeries. Patients and methods From May 2023 through September 2023, 150 patients hospitalized in the Urology Department at Al-Azhar University Hospitals of Assiut for urological surgery were eligible for this prospective study. They had a UTI within 30 days after urological surgery and underwent urine culture and sensitivity. Results There was high sensitivity of isolated organisms to imipenem in 65 (43.33%) patients, to meropenem in 58 (38.67%) patients, to ciprofloxacin in 29 (19.33%) patients, to cefoperazone-sulbactam in 10 (6.67%) patients, to aztreonam in nine (6%) patients, to ceftriaxone in eight (5.33%) patients, to azithromycin in four (2.67) patients, to amoxicillin and clavulanic acid in two (1.33%) patients, to cephalexin in one (0.67%) patient, to vancomycin in one(0.67%) patient, to erythromycin in one (0.67%) patient, to cefepime one (0.67%) in one (0.67%) patient, and to cefotaxime in one (0.67%) patient. Conclusion The isolated organism was Escherichia coli in 100 (66.66%) patients, Klebsiella pneumoniae in 26 (17.2%) patients, Pseudomonas aeruginosa in 12 (8%) patients, Staphylococcus saprophyticus in 10 (6.66%) patients, and Staphylococcus epidermidis in two (1.3%) patients. There was high sensitivity of isolated organisms to imipenem in 98 (65.3%) patients, and there was moderate sensitivity of isolated organisms to cefoperazone-sulbactam in 68 (45.3%) patients, to azithromycin in 68 (45.3%) patients.
format Article
id doaj-art-eb6e40a99b0542779de7df2395342fcc
institution OA Journals
issn 1687-1693
language English
publishDate 2025-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Al-Azhar Assiut Medical Journal
spelling doaj-art-eb6e40a99b0542779de7df2395342fcc2025-08-20T02:10:39ZengWolters Kluwer Medknow PublicationsAl-Azhar Assiut Medical Journal1687-16932025-01-0123111111710.4103/azmj.azmj_71_24Bacterial diversity in urinary tract infections after urological surgeriesAbdehamead A.A.F. MohamedKhaled M. KhalifaAlaa R. MahmoudAhmed A.A. KasimBackground and aim Urinary tract infections (UTIs) are complications following urological surgeries, with rates depending on the type of procedure and patient population. Patient outcomes, such as morbidity, hospital stay, and healthcare expenditures, can be greatly affected by UTIs. We aim to investigate the bacterial diversity in UTIs after urological surgeries. Patients and methods From May 2023 through September 2023, 150 patients hospitalized in the Urology Department at Al-Azhar University Hospitals of Assiut for urological surgery were eligible for this prospective study. They had a UTI within 30 days after urological surgery and underwent urine culture and sensitivity. Results There was high sensitivity of isolated organisms to imipenem in 65 (43.33%) patients, to meropenem in 58 (38.67%) patients, to ciprofloxacin in 29 (19.33%) patients, to cefoperazone-sulbactam in 10 (6.67%) patients, to aztreonam in nine (6%) patients, to ceftriaxone in eight (5.33%) patients, to azithromycin in four (2.67) patients, to amoxicillin and clavulanic acid in two (1.33%) patients, to cephalexin in one (0.67%) patient, to vancomycin in one(0.67%) patient, to erythromycin in one (0.67%) patient, to cefepime one (0.67%) in one (0.67%) patient, and to cefotaxime in one (0.67%) patient. Conclusion The isolated organism was Escherichia coli in 100 (66.66%) patients, Klebsiella pneumoniae in 26 (17.2%) patients, Pseudomonas aeruginosa in 12 (8%) patients, Staphylococcus saprophyticus in 10 (6.66%) patients, and Staphylococcus epidermidis in two (1.3%) patients. There was high sensitivity of isolated organisms to imipenem in 98 (65.3%) patients, and there was moderate sensitivity of isolated organisms to cefoperazone-sulbactam in 68 (45.3%) patients, to azithromycin in 68 (45.3%) patients.https://journals.lww.com/10.4103/azmj.azmj_71_24bacterial diversityurinary tract infectionsurological surgeries
spellingShingle Abdehamead A.A.F. Mohamed
Khaled M. Khalifa
Alaa R. Mahmoud
Ahmed A.A. Kasim
Bacterial diversity in urinary tract infections after urological surgeries
Al-Azhar Assiut Medical Journal
bacterial diversity
urinary tract infections
urological surgeries
title Bacterial diversity in urinary tract infections after urological surgeries
title_full Bacterial diversity in urinary tract infections after urological surgeries
title_fullStr Bacterial diversity in urinary tract infections after urological surgeries
title_full_unstemmed Bacterial diversity in urinary tract infections after urological surgeries
title_short Bacterial diversity in urinary tract infections after urological surgeries
title_sort bacterial diversity in urinary tract infections after urological surgeries
topic bacterial diversity
urinary tract infections
urological surgeries
url https://journals.lww.com/10.4103/azmj.azmj_71_24
work_keys_str_mv AT abdehameadaafmohamed bacterialdiversityinurinarytractinfectionsafterurologicalsurgeries
AT khaledmkhalifa bacterialdiversityinurinarytractinfectionsafterurologicalsurgeries
AT alaarmahmoud bacterialdiversityinurinarytractinfectionsafterurologicalsurgeries
AT ahmedaakasim bacterialdiversityinurinarytractinfectionsafterurologicalsurgeries